This CNBC Cures episode is a deeply personal interview between Becky Quick and investor Guy Spier about living with glioblastoma and how a terminal diagnosis reshaped his priorities. The conversation moves from his cancer journey and treatment options to the emotional impact on family, then back to his investing career, Buffett influence, and why money matters less now than presence, love, and meaning.
Watch on YouTube ›Get the market thesis, key claims, assets, contradictions, and follow-up questions from any financial video — then unlock a version personalized to your portfolio, watchlist, and favorite speakers.
Guy Spier says his life changed the day he had a seizure on the drive back from skiing and woke up in a helicopter headed to hospital, where he learned he had a brain tumor. He explains that after a first surgery, then worsening focal seizures in 2025, and then a third surgery in December, he concluded he could no longer keep running his investment fund, Aquamarine, and returned outside investors’ money. The core of his testimony is not financial; it is existential. He repeatedly says that once he understood the prognosis, “Who cares about money at that point?” and that every day now feels like a gift. He gives a straightforward medical description of glioblastoma: a difficult-to-remove brain cancer that infiltrates surrounding tissue like “seeds in the ground” rather than being a cleanly excisable tumor. …
Near term, the actionable read is medical rather than market-driven: Spier is in active treatment selection mode, so the immediate risks are seizure recurrence and neurological decline. For the investing angle, the key tactical signal is that he has exited outside capital and is no longer a live fund-manager setup.
Over the next few months, the likely path is continued experimental therapy, possible trial enrollment, and a gradually more personal allocation of his resources toward treatment and research. The setup changes materially only if one of the next therapies stabilizes symptoms or if another surgery/seizure cycle forces a sharper decline.
Structurally, the interview argues that time scarcity fundamentally rewrites the utility function of a successful investor: wealth stops mattering as much as lived experience, honesty, and family. It also reinforces a long-run thesis that rare-disease innovation needs deliberate capital because the market alone will underfund small, complex patient populations.
Guy Spier was diagnosed with glioblastoma after a seizure on the drive home from skiing, and his life changed immediately.
He recounts the seizure, helicopter transfer, MRI, and realization he had a brain tumor.
He closed his fund and returned outside investors’ money because repeated seizures and surgeries made continuing impossible.
He says the treatment hadn't worked and he could not keep running the fund.
Glioblastoma is hard to treat because it infiltrates the brain like seeds in the ground and cannot usually be fully removed.
He explains the biology of the tumor and why surgery is limited.
What happened when you first realized something was wrong after skiing with your family?
He had a grand mal seizure on the drive back from skiing, was taken by helicopter to hospital, and woke up the next day to learn he had a brain tumor. He says his life changed completely that day and that he initially did not even know brain tumors existed.
Did the doctors tell you that you had to keep your health condition secret from investors?
He says he was allowed to say he had a brain tumor and that it had been removed, but the lawyers did not want language suggesting his performance had suffered. He explains that they were worried investors could claim they had not been told in time.
How did you decide what to say in your letter and come to terms with where you are now?
He says waking up to the diagnosis felt like a nightmare, and he contrasts that with ordinary mornings when people realize it was only a dream. The answer is reflective rather than directly describing a drafting process, but it shows how he framed the experience emotionally.
Unlock the full claims, asset map, scores, related transcripts, follow-up questions, and AI chat — shaped around your portfolio, watchlist, favorite speakers, and risks.
